Raras
Buscar doenças, sintomas, genes...
Apraxia progressiva primária da fala
ORPHA:314566CID-10 · G31.8DOENÇA RARA

A Degeneração ganglionar córtico-basal ou Síndrome corticobasal é uma rara doença neurodegenerativa crónica, caracterizada por distúrbios do movimento, cognição e comportamento com várias possíveis patologias subjacentes, incluindo a degeneração corticobasal. Apresenta-se de forma insidiosa e é lentamente progressiva. Encontra-se classificada na categoria de doença Parkinson plus, ainda que esta designacao esteja a ficar em desuso. Patologicamente falando, considera-se uma tauopatia. De difícil diagnóstico, deve-se considerar em pessoas que apresentem qualquer combinação de características extrapiramidais, apraxia ou outros sinais parietais, afasia e fenómenos de membros alheios.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distúrbio neurológico raro que afeta a capacidade de planejar e sequenciar os movimentos musculares necessários para a fala, resultando em fala distorcida e de difícil compreensão, que piora progressivamente. A causa e a herança são desconhecidas.

Publicações científicas
77 artigos
Último publicado: 2026 Mar 9

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
16
pacientes catalogados
Início
Adult
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G31.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico77PubMed
Últimos 10 anos70publicações
Pico202413 papers
Linha do tempo
2026Hoje · 2026🧪 1991Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Apraxia progressiva primária da fala

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
70 papers (10 anos)
#1

Deep learning-derived measures of sound-level accuracy in primary progressive apraxia of speech: A feasibility pipeline with descriptive evidence from two cases.

Clinical linguistics &amp; phonetics2026 Mar 09

Primary Progressive Apraxia of Speech (PPAOS) is a neurodegenerative motor speech disorder marked by disrupted speech planning and programming. This study demonstrates the implementation and interpretability of phonological-class-based posterior probability values generated by Phonet (a deep learning model) in two individuals with PPAOS (one phonetic, one prosodic predominant), across different speech rates and delayed auditory feedback (DAF) settings. Phonet generated frame-level posterior probabilities for phonological classes, which were aggregated and aligned with segment durations. The prosodic subtype showed higher, more stable articulatory values and improvements under DAF, while the phonetic subtype showed greater variability and sensitivity to condition changes. Results were consistent with expert articulatory judgements of sound errors. These findings demonstrate Phonet's potential to provide interpretable, segment-level measures of articulatory performance and suggest its utility in monitoring treatment-related articulatory changes in motor speech disorders. Further research is needed to assess its broader clinical applicability.

#2

What Is in a Label? The Importance of Clinical Specificity and Challenges of Diagnostic Evolution in Progressive Speech-Language Disorders.

American journal of speech-language pathology2026 Mar 10

This viewpoint addresses the complexity of the nomenclature of progressive speech-language disorders, which often exists at the intersection of descriptive symptoms, clinical syndromes, and underlying neuropathology. Using primary progressive apraxia of speech (PPAOS) as an example, we explore how overlapping diagnostic frameworks employed by speech-language pathologists, neurologists, and other clinicians and researchers can lead to different diagnostic labels that may evolve throughout disease progression. These discrepancies and changes can complicate patient understanding, clinical care, and affect eligibility for clinical trials. We highlight the importance of diagnostic specificity, flexibility, and multidisciplinary collaboration in improving patient counseling, prognostication, treatment planning, and clinical research alignment, particularly in the context of the growing number of clinical trials and specialized, multidisciplinary clinics. This viewpoint explores how symptom-based, syndrome-based, and pathology-based diagnoses can work together to support patient care and research. Accurate and specific diagnosis of speech-language disorders has important implications for patient understanding of their condition, identity, prognostic accuracy, access to care, clinical trial enrollment, and treatment planning and efficacy. Misdiagnosis or vague labeling can result in inappropriate interventions, delayed support, and skewed research findings. We argue that multidisciplinary collaboration and flexibility in recognizing evolving symptom-based and syndrome-based labels over the disease course-and as the fields learn more-is essential to empower patients with accurate, actionable information. Embracing both the specificity and the complexity of progressive speech-language disorders can both enhance communication and facilitate research.

#3

Clinicopathological and Neuroimaging Correlates of Disease Duration in Primary Progressive Apraxia of Speech.

European journal of neurology2025 Sep

Primary progressive apraxia of speech is a neurodegenerative disorder characterized by early, isolated speech impairment due to impairment of motor speech planning and programming. Patients with PPAOS have varying disease durations from the estimated onset of the first symptom to death. Clinicopathological and neuroimaging features related to disease duration are unknown for PPAOS. We determine whether clinical, neuroimaging, or pathological features are associated with disease duration in primary progressive apraxia of speech (PPAOS). We analyzed data from 41 PPAOS participants who were enrolled and longitudinally followed to death in NIH-funded studies over 15 years. Demographic, clinical, and genetic features were abstracted. Brain volumes of cortical, subcortical, and brainstem regions were calculated. Regional tau lesion count (burden) was assessed histologically. Spearman rank correlations were performed between disease duration and variables of interest, followed by multiple regression analyses. Disease duration did not correlate with any baseline demographic, clinical, or pathologic features. Shorter disease duration correlated with a faster rate of behavioral change and of apraxia of speech severity over time, smaller baseline volumes of the superior frontal lobe and supplementary motor cortex, and higher tau burden in the locus ceruleus (ρ = -0.5, p = 0.03). Multiple regression analysis identified rate of behavioral change and volume loss in the superior frontal lobe as key clinical and neuroimaging variables, respectively. In patients with PPAOS, we found shorter disease duration to be related to behavioral dyscontrol and involvement of the frontal lobe, as well as a higher burden of 4-repeat tau lesions in the locus ceruleus.

#4

Understanding the mind-brain relationship through focal neurodegenerative pathology.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025 Oct

This paper considers the contribution that observations of neurodegenerative diseases can make to our understanding of the 'mind-brain' relationship. The theoretical context in which cognitive models have been implemented by evidence from brain-damaged patients and the contribution of neuroimaging are briefly described. Reasons why neurodegenerative pathologies, as 'systems' pathologies, are potentially useful in providing complementary information to that obtained in focal vascular pathologies are reported and two specific examples, semantic dementia and primary progressive apraxia of speech, are discussed. While recognising the role of functional neuroimaging, priority should be given to the study of patients with brain damage, especially of a neurodegenerative nature, to legitimise the relationship between specific functions and specific structures (systems).

#5

Dysphagia and Mortality Risk in Individuals With Primary Progressive Apraxia of Speech.

Annals of clinical and translational neurology2025 Apr 24

Individuals with primary progressive apraxia of speech (PPAOS) often develop parkinsonism and dysphagia. To evaluate the clinical correlates and impact of dysphagia in this population, we compared enrollment visit data between individuals with (n = 12) versus individuals without (n = 44) dysphagia symptoms. The group with dysphagia had more motor speech symptoms and parkinsonism. Longitudinal analysis revealed that almost everyone developed dysphagia before dying; the average time to death after developing dysphagia was 5.43 years and complications of dysphagia resulted in mortality for 35% of the individuals for whom data were available. These results emphasize the need for dysphagia management and provide useful prognostic estimates.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC51 artigos no totalmostrando 70

2026

Deep learning-derived measures of sound-level accuracy in primary progressive apraxia of speech: A feasibility pipeline with descriptive evidence from two cases.

Clinical linguistics &amp; phonetics
2026

What Is in a Label? The Importance of Clinical Specificity and Challenges of Diagnostic Evolution in Progressive Speech-Language Disorders.

American journal of speech-language pathology
2025

Clinicopathological and Neuroimaging Correlates of Disease Duration in Primary Progressive Apraxia of Speech.

European journal of neurology
2025

Understanding the mind-brain relationship through focal neurodegenerative pathology.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Cause of death for patients who present with primary progressive apraxia of speech.

Parkinsonism &amp; related disorders
2025

Dysphagia and Mortality Risk in Individuals With Primary Progressive Apraxia of Speech.

Annals of clinical and translational neurology
2025

Neuroradiological insights into primary progressive apraxia of speech: a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Unveiling the enigmatic: Primary progressive apraxia of speech - A case report.

Clinical parkinsonism &amp; related disorders
2024

Progression of Motor Speech Function in Speakers With Primary Progressive Apraxia of Speech.

Journal of speech, language, and hearing research : JSLHR
2024

Automatic Speech Recognition in Primary Progressive Apraxia of Speech.

Journal of speech, language, and hearing research : JSLHR
2024

Incidence of Primary Progressive Apraxia of Speech and Primary Progressive Aphasia in Olmsted County, MN, 2011-2022.

Neurology
2024

Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease.

Neurology
2024

The yes-no reversal phenomenon in patients with primary progressive apraxia of speech.

Cortex; a journal devoted to the study of the nervous system and behavior
2024

Multimodal cross-examination of progressive apraxia of speech by diffusion tensor imaging-based tractography and Tau-PET scans.

Human brain mapping
2024

Efficacy of LSVT LOUD® on Phonatory Control and Voice Quality in Patients with Primary Progressive Apraxia of Speech: Case Studies.

Brain sciences
2024

Progression to corticobasal syndrome: a longitudinal study of patients with nonfluent primary progressive aphasia and primary progressive apraxia of speech.

Journal of neurology
2024

Primary Progressive Apraxia of Speech Caused by TDP-43: A Case Report.

Neurology. Genetics
2024

Characterizing Speech Errors Across Primary Progressive Apraxia of Speech Subtypes.

Journal of speech, language, and hearing research : JSLHR
2023

Amyloid and Tau PET Positivity in Progressive Agrammatic Aphasia and Apraxia of Speech.

Journal of Alzheimer's disease : JAD
2024

Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum.

Brain : a journal of neurology
2024

Behavioral Treatment for Speech and Language in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech: A Systematic Review.

Neuropsychology review
2024

Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum.

Brain : a journal of neurology
2023

Acoustic Analysis and Neuroimaging Correlates of Diadochokinetic Rates in Mild-Moderate Primary Progressive Apraxia of Speech.

Brain and language
2023

Speech Motor Profiles in Primary Progressive Aphasia.

American journal of speech-language pathology
2023

Patterns of hemispheric compromise in primary progressive apraxia of speech: From clinical profiling to differential diagnosis.

European journal of neurology
2023

Clinicopathological associations of hemispheric dominance in primary progressive apraxia of speech.

European journal of neurology
2023

Shouting from far away: three poems about living with speechlessness.

Practical neurology
2023

The many faces of globular glial tauopathy: A clinical and imaging study.

European journal of neurology
2022

Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech.

Neurobiology of aging
2022

Cross-Sectional and Longitudinal Assessment of Behavior in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.

Dementia and geriatric cognitive disorders
2022

Tractography of supplementary motor area projections in progressive speech apraxia and aphasia.

NeuroImage. Clinical
2022

A Preliminary Report of Network Electroencephalographic Measures in Primary Progressive Apraxia of Speech and Aphasia.

Brain sciences
2022

Pure Prosodic Type of Primary Progressive Apraxia of Speech Mimicking Nonfluent Aphasia and Later Progressing to Corticobasal Syndrome.

Alzheimer disease and associated disorders
2021

Word Fluency Test Performance in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech.

American journal of speech-language pathology
2021

Assessing Change in Communication Limitations in Primary Progressive Apraxia of Speech and Aphasia: A 1-Year Follow-Up Study.

American journal of speech-language pathology
2021

Survival Analysis in Primary Progressive Apraxia of Speech and Agrammatic Aphasia.

Neurology. Clinical practice
2021

Coming to Terms with a Conundrum: A Case of Primary Progressive Apraxia of Speech due to Corticobasal Degeneration?

Case reports in neurology
2022

Speech rate increase in primary progressive apraxia of speech and its cost on articulatory accuracy.

Clinical linguistics &amp; phonetics
2022

Neuropsychological Profiles of Patients with Progressive Apraxia of Speech and Aphasia.

Journal of the International Neuropsychological Society : JINS
2021

Primary Progressive Apraxia of Speech: From Recognition to Diagnosis and Care.

Aphasiology
2021

A Preliminary Look Into the Clinical Evolution of Motor Speech Characteristics in Primary Progressive Apraxia of Speech in Québec French.

American journal of speech-language pathology
2021

Progressive apraxia of speech in Quebec French speakers: A case series.

International journal of language &amp; communication disorders
2021

A Longitudinal Evaluation of Speech Rate in Primary Progressive Apraxia of Speech.

Journal of speech, language, and hearing research : JSLHR
2020

Primary progressive apraxia of speech: A further piece in the progressive supranuclear/corticobasal degeneration spectrum jigsaw.

Parkinsonism &amp; related disorders
2020

The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.

Parkinsonism &amp; related disorders
2020

Communication Limitations in Patients With Progressive Apraxia of Speech and Aphasia.

American journal of speech-language pathology
2020

Corrigendum to "Prosodic and phonetic subtypes of primary progressive apraxia of speech" [Brain Lang. 184 (2018) 54-65].

Brain and language
2020

Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech.

Cortex; a journal devoted to the study of the nervous system and behavior
2019

Electroencephalography in Primary Progressive Aphasia and Apraxia of Speech.

Aphasiology
2020

Western Aphasia Battery-Revised Profiles in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech.

American journal of speech-language pathology
2019

High frequency repetitive transcranial magnetic stimulation for primary progressive apraxia of speech: A case series.

Brain stimulation
2021

Language impairment in progressive supranuclear palsy and corticobasal syndrome.

Journal of neurology
2019

Primary Progressive Aphasias and Apraxia of Speech.

Continuum (Minneapolis, Minn.)
2019

Sub-classification of apraxia of speech in patients with cerebrovascular and neurodegenerative diseases.

Brain and cognition
2018

Clinical Progression in Four Cases of Primary Progressive Apraxia of Speech.

American journal of speech-language pathology
2018

Quantitative Analysis of Agrammatism in Agrammatic Primary Progressive Aphasia and Dominant Apraxia of Speech.

Journal of speech, language, and hearing research : JSLHR
2018

Prosodic and phonetic subtypes of primary progressive apraxia of speech.

Brain and language
2018

Disrupted functional connectivity in primary progressive apraxia of speech.

NeuroImage. Clinical
2018

Non-right handed primary progressive apraxia of speech.

Journal of the neurological sciences
2018

Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration.

Neurocase
2018

Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.

Cortex; a journal devoted to the study of the nervous system and behavior
2018

L'apport critique de l'évaluation de la communication dans le diagnostic précoce de l'apraxie primaire progressive de la parole.

Canadian journal on aging = La revue canadienne du vieillissement
2018

Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.

Brain : a journal of neurology
2017

A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: II. Validity Studies of the Pause Marker.

Journal of speech, language, and hearing research : JSLHR
2017

A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: III. Theoretical Coherence of the Pause Marker with Speech Processing Deficits in Childhood Apraxia of Speech.

Journal of speech, language, and hearing research : JSLHR
2017

Temporal acoustic measures distinguish primary progressive apraxia of speech from primary progressive aphasia.

Brain and language
2017

Tracking the development of agrammatic aphasia: A tensor-based morphometry study.

Cortex; a journal devoted to the study of the nervous system and behavior
2016

Primary Progressive Orofacial Apraxia: A Ten-Year Long Follow-Up Case Report.

Journal of Alzheimer's disease : JAD
2016

When the left brain's away, the right will play--Emergent artistic proficiency in primary progressive apraxia of speech.

Cortex; a journal devoted to the study of the nervous system and behavior
2015

Primary progressive apraxia of speech: clinical features and acoustic and neurologic correlates.

American journal of speech-language pathology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Apraxia progressiva primária da fala.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Apraxia progressiva primária da fala

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Deep learning-derived measures of sound-level accuracy in primary progressive apraxia of speech: A feasibility pipeline with descriptive evidence from two cases.
    Clinical linguistics &amp; phonetics· 2026· PMID 41800702mais citado
  2. What Is in a Label? The Importance of Clinical Specificity and Challenges of Diagnostic Evolution in Progressive Speech-Language Disorders.
    American journal of speech-language pathology· 2026· PMID 41499662mais citado
  3. Clinicopathological and Neuroimaging Correlates of Disease Duration in Primary Progressive Apraxia of Speech.
    European journal of neurology· 2025· PMID 40993958mais citado
  4. Understanding the mind-brain relationship through focal neurodegenerative pathology.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2025· PMID 40833450mais citado
  5. Dysphagia and Mortality Risk in Individuals With Primary Progressive Apraxia of Speech.
    Annals of clinical and translational neurology· 2025· PMID 40272101mais citado
  6. Cause of death for patients who present with primary progressive apraxia of speech.
    Parkinsonism Relat Disord· 2025· PMID 40706471recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:314566(Orphanet)
  2. MONDO:0017803(MONDO)
  3. GARD:21377(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q55346005(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Apraxia progressiva primária da fala
Compêndio · Raras BR

Apraxia progressiva primária da fala

ORPHA:314566 · MONDO:0017803
Prevalência
<1 / 1 000 000
Casos
16 casos conhecidos
Herança
Unknown
CID-10
G31.8 · Outras doenças degenerativas especificadas do sistema nervoso
Início
Adult
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5848171
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades